retatrutide clinical data Retatrutide—A Game Changer in Obesity Pharmacotherapy Retatrutide: A Multi-Receptor Approach to

Woodward, Effects of dulaglutide and insulin glargine on estimated glomerular filtration rate in a real-world setting

Moreover, expanding indications aims to explore new markets

It breaks down almost instantly

Sign Up Quick Summary Retatrutide is an investigational triple-hormone receptor agonist that targets GLP-1, GIP, and glucagon pathways simultaneously, potentially offering enhanced benefits for women with PCOS who struggle with weight management and insulin resistance

Beyond mechanical effects, emerging evidence suggests GLP-1 receptor agonists may exert anti-inflammatory properties that could theoretically benefit joint health